Incidence and clearance of oral human papillomavirus infection in men: The HIM cohort study

The Lancet

Volumn 382, Issue 9895, 2013, Pages 877-887

  Kreimer, Aimée R ^a   Pierce Campbell, Christine M ^b   Lin, Hui Yi ^b   Fulp, William ^b   Papenfuss, Mary R ^b   Abrahamsen, Martha ^b   Hildesheim, Allan ^a   Villa, Luisa L ^c,d   Salmerón, Jorge J ^e   Lazcano Ponce, Eduardo ^f   Giuliano, Anna R ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d School of Medicine   (Brazil)

^e INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^f INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAZIL; COHABITING PERSON; COHORT ANALYSIS; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MARRIED PERSON; MEXICO; MOUTH INFECTION; ORAL HUMAN PAPILLOMAVIRUS INFECTION; PAPILLOMAVIRUS INFECTION; PERSISTENT INFECTION; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR; UNITED STATES;

EID: 84883551439     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)60809-0     Document Type: Article

References (31)

1. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29: 4294-301.
2. Hong AM, Grulich AE, Jones D, et al Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets. Vaccine 2010; 28: 3269-72.
3. Jemal A, Simard EP, Dorell C, et al Annual report to the nation on the status of cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 2013; 105: 175-201.
4. Nasman A, Attner P, Hammarstedt L., et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009; 125: 362-66.
5. D'Souza G., Kreimer AR, Viscidi R, et al Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944-56.
6. Sanders AE, Slade GD, Patton LL National prevalence of oral HPV infection and related risk factors in the U.S. adult population. Oral Dis 2012; 18: 430-41.
7. Gillison ML, Broutian T, Pickard R.K., et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012; 307: 693-703.
8. Marur S, D'Souza G, Westra WH, Forastiere AA HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010; 11: 781-89.
9. Schiffman M., Castle PE, Jeronimo J, Rodriguez A.C., Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007; 370: 890-907.
10. Ho GY, Burk RD, Klein S, et al Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995; 87: 1365-71.
11. Kreimer AR, Bhatia RK, Messeguer A.L., González P, Herrero R., Giuliano AR Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis 2010; 37: 386-91.
12. Kreimer AR, Villa A, Nyitray A.G., et al. The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol Biomarkers Prev 2011; 20: 172-82.
13. Mork J, Lie AK, Glattre E, et al Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 2001; 344: 1125-31.
14. Giuliano AR, Lazcano-Ponce E, Villa L.L., et al. The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev 2008; 17: 2036-43.
15. Giuliano AR, Lee JH, Fulp W, et al Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet 2011; 377: 932-40.
16. Gravitt PE, Peyton CL, Apple R.J., Wheeler CM Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998; 36: 3020-27.
17. Gravitt PE, Peyton CL, Alessi T.Q., et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38: 357-61.
18. Bouvard V, Baan R, Straif K., et al. A review of human carcinogens-Part B: biological agents. Lancet Oncol 2009; 10: 321-22.
19. Ying Z, Wei LJ The Kaplan-Meier estimate for dependent failure time observations. J Multivar Anal 1994; 50: 17-29.
20. Nyitray AG, Carvalho da Silva RJ, Baggio ML, et al. Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study. J Infect Dis 2011; 204: 1711-22.
21. Edelstein ZR, Schwartz SM, Hawes S, et al Rates and determinants of oral human papillomavirus infection in young men. Sex Transm Dis 2012; 39: 860-67.
22. Pickard RK, Xiao W, Broutian T.R., He X., Gillison ML The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years. Sex Transm Dis 2012; 39: 559-66.
23. Winer RL, Lee SK, Hughes J.P., Adam DE, Kiviat NB, Koutsky LA Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003; 157: 218-26.
24. IARC. Human papillomaviruses-IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 90. Lyon: International Agency for Reseach on Cancer, 2007.
25. Rodríguez A.C., Schiffman M, Herrero R, et al Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst 2010; 102: 315-24.
26. Gillison ML, D'Souza G, Westra W, et al Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008; 100: 407-20.
27. Chaturvedi AK, D'Souza G, Gillison M, Katki H. Estimated population-level burden of HPV-positive oropharynx cancers among smokers and never smokers in the United States. 26th International Papillomavirus Conference; Montreal, Canada; July 3-8, 2010. P-575.
28. D'Souza G., Agrawal Y, Halpern J., Bodison S, Gillison ML Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis 2009; 199: 1263-69.
29. Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun 2010; 34: J258-65.
30. Castle PE. How does tobacco smoke contribute to cervical carcinogenesis? J Virol 2008; 82: 6084-85.
31. Fakhry C, Sugar E, D'Souza G, Gillison M. Two-week versus six-month sampling interval in a short-term natural history study of oral HPV infection in an HIV-positive cohort. PLoS One 2010; 5: e11918.